Immunicom is developing a non-drug-based cancer therapy with the potential to reduce treatment side effects, enhance therapy response rates and improve cancer patients’ quality of life – all at significantly lower costs and without the side effects and complications prevalent in existing immunotherapy approaches. Immunicom's cancer therapy can allow the body’s natural immune system to directly attack cancer while enhancing the effects of other cancer treatments that may be used concurrently.

Biotechnology

Immunicom

Amir Jafri

Lawrence Florin

Adam Ostrowski

Kamel Djazouli

Dave L. Lopez

Marilyn Panahi

Raju Chauhan

Julie Tubbs

Johan Louw

Steven Josephs

Steve Prince

Leadership Team

Business Operations

Medical and Clinical Operations Team

Quality Assurance Team

Teams at Immunicom

Leadership Team

Business Operations

Medical and Clinical Operations Team

Quality Assurance Team